Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review

por Sherwood, Matthew W., Melloni, Chiara, Jones, W. Schuyler, Washam, Jeffrey B., Hasselblad, Vic, Dolor, Rowena J.
Publicado 2015

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

por Jaspers Focks, Jeroen, Brouwer, Marc A, Wojdyla, Daniel M, Thomas, Laine, Lopes, Renato D, Washam, Jeffrey B, Lanas, Fernando, Xavier, Denis, Husted, Steen, Wallentin, Lars, Alexander, John H, Granger, Christopher B, Verheugt, Freek W A
Publicado 2016

Cangrelor Use Patterns and Transition to Oral P2Y(12) Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

por Rymer, Jennifer A., Bhatt, Deepak L., Angiolillo, Dominick J., Diaz, Miguel, Garratt, Kirk N., Waksman, Ron, Edwards, Laura, Tasissa, Gudaye, Salahuddin, Khalid, El‐Sabae, Hijrah, Dell’Anna, Carmen, Davidson‐Ray, Linda, Washam, Jeffrey B., Ohman, E. Magnus, Wang, Tracy Y.
Publicado 2022

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF

por Washam, Jeffrey B., Holmes, DaJuanicia N., Thomas, Laine E., Pokorney, Sean D., Hylek, Elaine M., Fonarow, Gregg C., Mahaffey, Kenneth W., Gersh, Bernard J., Kowey, Peter R., Ansell, Jack E., Go, Alan S., Reiffel, James A., Freeman, James V., Singer, Daniel E., Naccarelli, Gerald, Blanco, Rosalia, Peterson, Eric D., Piccini, Jonathan P.
Publicado 2018